Profile: Inovio Biomedical Corporation offers safe & effective DNA delivery method for next-generation vaccines, DNA vaccines for preventive and therapeutic purposes for cancers & chronic infectious diseases. Our Plasmid V930 is a therapeutic DNA vaccine candidate designed to target cancers expressing the antigens HER-2 & CEA, which include breast, colorectal, ovarian, and non-small cell lung cancer. Our selective electrochemical tumor ablation therapy, using its core electroporation technology in conjunction with a chemotherapeutic agent called bleomycin for locally treating solid tumors is designed to selectively kill cancerous cells and to minimize cosmetic or functional detriments often caused by the surgical removal of predominantly healthy tissue typically treated around a tumor.